Home Companies Amgen

Amgen

Gilead And EVOQ Ink Deal Worth up to $685M For Autoimmune Diseases
Amgen

Gilead And EVOQ Ink Deal Worth up to $685M For Autoimmune Diseases

0
UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank Sequencing
Amgen

UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank Sequencing

0
Oxford Nanopore Attracts $66M Equity Investment from Amgen
Amgen

Oxford Nanopore Attracts $66M Equity Investment from Amgen

0
Illumina Wins FDA Approval for NGS-Based Colorectal Cancer CDx
Amgen

Illumina Wins FDA Approval for NGS-Based Colorectal Cancer CDx

0
Dako, Amgen Expand Cancer CDx Collaboration
Agilent Technologies

Dako, Amgen Expand Cancer CDx Collaboration

0

Trending

High Levels of CPS1 in Blood Indicate Need for Liver Transplant

High Levels of CPS1 in Blood Indicate Need for Liver Transplant

Preventative Compound That Prevents <i>C. diff</i> Infection Identified

Preventative Compound That Prevents C. diff Infection Identified

Age Not Weight Is Best Predictor of Diabetes Risk

Age Not Weight Is Best Predictor of Diabetes Risk

RepRNA Vaccine Antibodies Transfer in Utero

RepRNA Vaccine Antibodies Transfer in Utero

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine